Paul Kluetz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Paul Kluetz
Jul 3, 2024, 04:18 |
Blog
FDA and WHOSTP discuss increasing clinical trials access and lowering barriers to participation
FDA Oncology shared on X: “FDA Oncology Center's Paul Kluetz, Rick Pazdur, Donna Rivera attended…
Jul 1, 2024, 12:51 |
Blog
Career Development Beyond the FDA-AACR Oncology Educational Fellowship
FDA Oncology posted on X: "Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship…
Jan 8, 2024, 09:57 |
Insight
Vivek Subbiah: Dr. Timil Patel and colleagues from the FDA Oncology call upon the drug development community to find ways to make clinical trials simpler
Vivek Subbiah shared on X: "Since clinical trials in oncology that are submitted for regulatory…
Oct 9, 2023, 18:54 |
Blog
Ishwaria Subbiah: And that’s a wrap! Cheers from your planning committee for the 2023 Workshop on Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care, co-hosted by ASCO and National Cancer Policy Forum!
Oct 1, 2023, 16:07 |
Blog
Vivek Subbiah: Fantastic keynote lecture on “The FDA perspective on early phase pre-market dose optimization” by the amazing Dr. Paul Kluetz.
Vivek Subbiah shared on X/Twitter: “Fantastic keynote lecture on “The FDA perspective on early phase pre-market…
All:
5
Posts:
1 - 100
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
Facebook
RSS Feed
Twitter
Linkedin
Youtube